The management of infantile spasms

Archives of Disease in Childhood

Volumn 93, Issue 6, 2008, Pages 462-463

  Desauerre, Isabelle ^a   Nabbout, Rima ^a,b,c   Dulac, Olivier ^a,b,c  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b INSERM   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CORTICOTROPIN; OXCARBAZEPINE; PYRIDOXAL 5 PHOSPHATE; PYRIDOXINE; STEROID; TOPIRAMATE; VIGABATRIN; ANTICONVULSIVE AGENT;

AGYRIA; AICARDI SYNDROME; BRAIN SURGERY; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DISEASE SEVERITY; EDITORIAL; ELECTROENCEPHALOGRAPHY; EPILEPSY; EYE MOVEMENT; HORMONAL THERAPY; HUMAN; INFANTILE SPASM; MONOTHERAPY; PRIORITY JOURNAL; PSYCHOMOTOR DISORDER; RETINA DISEASE; RETINA TOXICITY; SPIKE WAVE; TOTAL CALLOSOTOMY; TUBEROUS SCLEROSIS; VISUAL FIELD; VISUAL FIELD DEFECT; ARTICLE; CHILD; CHILD DEVELOPMENT; DIFFERENTIAL DIAGNOSIS; DOSE RESPONSE; DRUG EFFECT; FEMALE; INFANT; MALE; NEWBORN; PHYSIOLOGY; PRESCHOOL CHILD; PROGNOSIS; PSYCHOMOTOR PERFORMANCE; TREATMENT OUTCOME;

ANTICONVULSANTS; CHILD; CHILD DEVELOPMENT; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; PROGNOSIS; PSYCHOMOTOR PERFORMANCE; SPASMS, INFANTILE; TREATMENT OUTCOME; VIGABATRIN;

EID: 45549098680     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2006.108803     Document Type: Editorial

References (25)

1. Lux A, Osborne J. A proposal for case definitions and outcome measures in studies of infantile spasms and West syndrome: consensus statement of the West Delphi group. Epilepsia 2004;45:1416-28.
2. Lux A, Osborne J. The influence of etiology upon ictal semiology, treatment decisions and long-term outcome in infantile spasms and West syndrome. Epilepsy Res 2006;70S:S77-S86.
3. Hrachovy RA, Frost JD Jr, Kellaway P. Hypsarrhythmia: variations on the theme. Epilepsia 1984;25:317-25.
4. Gastaut H, Pinsard N, Raybaud C, et al. Lissencephaly (agyria-pachygyria): clinical findings and serial EEG studies. Dev Med Child Neurol 1987;29:167-80.
5. Dulac O, Plouin P, Jambaque I. Predicting favorable outcome in idiopathic West syndrome. Epilepsia 1993;34:747-56.
6. Turner G, Partington M, Kerr B, et al. Variable expression of mental retardation, autism, seizures, and dystonic hand movements in two families with an identical ARX gene mutation. Am J Med Genet 2002;112:405-11.
7. Kivity S, Lerman P, Ariel R, et al. Long-term cognitive outcomes of a cohort of children with cryptogenic infantile spasms treated with high-dose adrenocorticotropic hormone. Epilepsia 2004;45:255-62.
8. Jambaque I, Chiron C. Dumas C, et al. Mental and behavioural outcome of infantile epilepsy treated by vigabatrin in tuberous sclerosis patients. Epilepsy Res 2000;38:151-60.
9. Eisermann MM, DeLaRaillere A, Dellatolas G, et al. Infantile spasms in Down syndrome-effects of delayed anticonvulsive treatment. Epilepsy Res 2003;55:21-7.
10. Chiron C, Nabbout R, Pinton F, et al. Brain functional imaging SPECT in agyria-pachygyria. Epilepsy Res 1996;24:109-17.
11. Baram TZ, Mitchell WG, Tournay A, et al. High-dose corticotropin (ACTH) versus prednisone for infantile spasms: a prospective, randomized, blinded study. Pediatrics 1996;97:375-9.
12. Elterman RD, Shields WD, Mansfield KA, et al. Randomized trial of vigabatrin in patients with infantile spasms. Neurology 2001;57:1416-21.
13. Chiron C, Dumas C, Jambaque I, et al. Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis. Epilepsy Res 1997;26:389-95.
14. Lux AL, Edwards SW, Hancock E, et al. The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial. Lancet 2004;364:1773-8.
15. Lux AL, Edwards SW, Hancock E, et al. The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial. Lancet Neurol 2005;4:712-17.
16. Mikaeloff Y, Plouin P, Dhondt JL, et al. Clinical and EEG video-polygraphic features of epileptic spasms in a child with dihydropteridine reductase deficiency. Efficiency of hydrocortisone. Epileptic Disord 2000;2:213-17.
17. Riikonen R. Cytomegalovirus infection and infantile spasms. Dev Med Child Neurol 1978;20:570-9.
18. Jeavons P, Bower BD. Infantile spasms. In: Vinken P, Bruyen G, eds. Handbook of clinical neurology: the epilepsies. Vol 15. Amsterdam: North Holland, 1974:219.
19. Vanhatalo S, Nousiainen I, Eriksson K, et al. Visual field constriction in 91 Finnish children treated with vigabatrin. Epilepsia 2002;43:748-56.
20. Nabbout R, Melki I, Gerbaka B, et al. Infantile spasms in Down syndrome: good response to a short course of vigabatrin. Epilepsia 2001;42:1580-3.
21. Kroll-Seger J, Kaminska A, Moutard ML, et al. Severe relapse of epilepsy after vigabatrin withdrawal: for how long should we treat symptomatic infantile spasms? Epilepsia 2007;48:612-13.
22. Chugani HT, Shields WD, Shewmon DA, et al. Infantile spasms: I. PET identifies focal cortical dysgenesis in cryptogenic cases for surgical treatment. Ann Neurol 1990;27:406-13.
23. Talwar D, Arora MS, Sher PK. EEG changes and seizure exacerbation in young children treated with carbamazepine. Epilepsia 1994;35:1154-9.
24. Kossoff EH, Pyzik PL, McGrogan JR, et al. Efficacy of the ketogenic diet for infantile spasms. Pediatrics 2002;109:780-3.
25. Pinard JM, Delalande O, Chiron C, et al. Callosotomy for epilepsy after West syndrome. Epilepsia 1999;40:1727-34.